Peer reviewed
Tirzepatide once weekly for the treatment of obesity
Randomized SURMOUNT-1 obesity trial of tirzepatide.
New England Journal of MedicinePublished 2022-06-04Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- New England Journal of Medicine
- Source type
- Peer reviewed
- Registry ID
nejm-tirzepatide-surmount1-video
Source usage
Linked from 4 pages
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.